Marc Tessier-Lavigne, the executive vice president for research and the chief scientific officer at Genentech, is leaving the company to take the helm of Rockefeller University in New York, reports the New York Times. Tessier-Lavigne will take up the position in March, succeeding Paul Nurse, who is returning to the UK to lead the Royal Society there. The Times notes that Tessier-Lavigne is the "first departure from the company’s top scientific ranks since its acquisition by Roche in March 2009," but adds that Tessier-Lavigne's departure is not related to the Roche-Genentech merger. "I wasn't looking to move away. In fact, this is probably the only job that could have lured me away from Genentech," he says. Tessier-Lavigne will also be the first Rockefeller president to come from industry, the Times adds.
See, You Can Go from Industry to Academia
Sep 09, 2010